Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
An International, Randomised, Double-Blind, Two-Arm Study To Evaluate The Safety And Efficacy Of Vandetanib 150 And 300mg/Day In Patients With Unresectable Locally Advanced Or Metastatic Medullary Thyroid Carcinoma With Progressive Or Symptomatic Disease
Status: Enrolling
Updated:  10/27/2015
Investigational Site Number 203002
mi
from
Olomouc,
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
An International, Randomised, Double-Blind, Two-Arm Study To Evaluate The Safety And Efficacy Of Vandetanib 150 And 300mg/Day In Patients With Unresectable Locally Advanced Or Metastatic Medullary Thyroid Carcinoma With Progressive Or Symptomatic Disease
Status: Enrolling
Updated: 10/27/2015
Investigational Site Number 203002
mi
from
Olomouc,
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Evanston
mi
from
Evanston, IL
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Evanston
mi
from
Evanston, IL
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Wichita
mi
from
Wichita, KA
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Dayton
mi
from
Dayton, OH
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Columbia River Oncology Program
mi
from
Portland, OR
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Columbia River Oncology Program
mi
from
Portland, OR
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Greenville
mi
from
Greenville, SC
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Northwest
mi
from
Tacoma, WA
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated:  10/27/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status: Enrolling
Updated: 10/27/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Phase I/II Trial of Subcutaneous Decitabine Maximizing Genomic Demethylation in Patients With Myelodysplastic Syndrome.
Status: Enrolling
Updated:  10/27/2015
University of Arizona Cancer Center
mi
from
Tucson, AZ
A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Phase I/II Trial of Subcutaneous Decitabine Maximizing Genomic Demethylation in Patients With Myelodysplastic Syndrome.
Status: Enrolling
Updated: 10/27/2015
University of Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Phase I/II Trial of Subcutaneous Decitabine Maximizing Genomic Demethylation in Patients With Myelodysplastic Syndrome.
Status: Enrolling
Updated:  10/27/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Phase I/II Trial of Subcutaneous Decitabine Maximizing Genomic Demethylation in Patients With Myelodysplastic Syndrome.
Status: Enrolling
Updated: 10/27/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Phase I/II Trial of Subcutaneous Decitabine Maximizing Genomic Demethylation in Patients With Myelodysplastic Syndrome.
Status: Enrolling
Updated:  10/27/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Phase I/II Trial of Subcutaneous Decitabine Maximizing Genomic Demethylation in Patients With Myelodysplastic Syndrome.
Status: Enrolling
Updated: 10/27/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer
A Randomized Phase II, Open-label Multicenter Trial of Panobinostat Monotherapy in Women With HER2 Positive Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/27/2015
UCLA
mi
from
Los Angeles, CA
Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer
A Randomized Phase II, Open-label Multicenter Trial of Panobinostat Monotherapy in Women With HER2 Positive Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/27/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Positron Emission Tomography in Prostate Cancer
Positron Emission Tomography in Prostate Cancer
Status: Enrolling
Updated:  10/28/2015
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
Saint Louis, MO
Positron Emission Tomography in Prostate Cancer
Positron Emission Tomography in Prostate Cancer
Status: Enrolling
Updated: 10/28/2015
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
Monitoring Targeted Lung Cancer Treatments With FDG-PET/CT
Status: Enrolling
Updated:  10/28/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
Monitoring Targeted Lung Cancer Treatments With FDG-PET/CT
Status: Enrolling
Updated: 10/28/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated:  10/28/2015
City of Hope Medical Center
mi
from
Duarte, CA
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated: 10/28/2015
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated:  10/28/2015
Scripps Green Hospital/Scripps Cancer Center
mi
from
La Jolla, CA
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated: 10/28/2015
Scripps Green Hospital/Scripps Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated:  10/28/2015
Ohio State University
mi
from
Columbus, OH
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated: 10/28/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Status: Enrolling
Updated:  10/28/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Status: Enrolling
Updated: 10/28/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
A Pre-Surgical, Randomized Clinical Trial of Genistein in Resectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  10/28/2015
UCLA
mi
from
Los Angeles, CA
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
A Pre-Surgical, Randomized Clinical Trial of Genistein in Resectable Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 10/28/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety & Health Improvement: Enhancing Law Enforcement Departments
Safety & Health Improvement: Enhancing Law Enforcement Departments
Status: Enrolling
Updated:  10/28/2015
Oregon Health and Science University
mi
from
Portland, OR
Safety & Health Improvement: Enhancing Law Enforcement Departments
Safety & Health Improvement: Enhancing Law Enforcement Departments
Status: Enrolling
Updated: 10/28/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
A Phase II Study of VEGF Blockade With Bevacizumab Combined With Autologous Tumor/Dendritic Cell Vaccine (DC Vaccine), Interleukin-2 (IL-2) and Interferon-α-2b (IFNα-2b) in Patients With Metastatic Renal Cell Carcinoma (RCC)
Status: Enrolling
Updated:  10/28/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
A Phase II Study of VEGF Blockade With Bevacizumab Combined With Autologous Tumor/Dendritic Cell Vaccine (DC Vaccine), Interleukin-2 (IL-2) and Interferon-α-2b (IFNα-2b) in Patients With Metastatic Renal Cell Carcinoma (RCC)
Status: Enrolling
Updated: 10/28/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
Status: Enrolling
Updated:  10/28/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
Status: Enrolling
Updated: 10/28/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
PHASE I/II TRIAL OF SEQUENTIAL TAXOL/IFOSFAMIDE AND DOSEINTENSIVE CARBOPLATIN/ETOPOSIDE WITH STEM CELL SUPPORT IN CISPLATIN-RESISTANT GERM CELL TUMOR PATIENTS WITH UNFAVORABLE PROGNOSTIC FEATURES
Status: Enrolling
Updated:  10/28/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
PHASE I/II TRIAL OF SEQUENTIAL TAXOL/IFOSFAMIDE AND DOSEINTENSIVE CARBOPLATIN/ETOPOSIDE WITH STEM CELL SUPPORT IN CISPLATIN-RESISTANT GERM CELL TUMOR PATIENTS WITH UNFAVORABLE PROGNOSTIC FEATURES
Status: Enrolling
Updated: 10/28/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Radiation Therapy Following Surgery to Remove Brain Metastases
Pilot Study of Adjuvant Fractionated Stereotactic Radiotherapy Following Surgical Removal of Cerebral Metastases
Status: Enrolling
Updated:  10/28/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Radiation Therapy Following Surgery to Remove Brain Metastases
Pilot Study of Adjuvant Fractionated Stereotactic Radiotherapy Following Surgical Removal of Cerebral Metastases
Status: Enrolling
Updated: 10/28/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Comprehensive Blood and Cancer Center
mi
from
Bakersfield, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Comprehensive Blood and Cancer Center
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
St Jude Heritage Health Foundation
mi
from
Fullerton, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
St Jude Heritage Health Foundation
mi
from
Fullerton, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Daniel Freeman Memorial Hospital
mi
from
Inglewood, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Daniel Freeman Memorial Hospital
mi
from
Inglewood, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
UCLA - Antelope Valley Cancer Center
mi
from
Lancaster, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
UCLA - Antelope Valley Cancer Center
mi
from
Lancaster, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Pacific Shores Medical Group
mi
from
Long Beach, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Pacific Shores Medical Group
mi
from
Long Beach, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Office of Eddie Hu, M.D.
mi
from
Monterey Park, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Office of Eddie Hu, M.D.
mi
from
Monterey Park, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Community Hospital of the Monterey Peninsula
mi
from
Monterey, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Community Hospital of the Monterey Peninsula
mi
from
Monterey, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Office of Jerome L. Rubin
mi
from
Monterey, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Office of Jerome L. Rubin
mi
from
Monterey, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Ventura County Hematology-Oncology Medical Group, Inc.
mi
from
Oxnard, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Ventura County Hematology-Oncology Medical Group, Inc.
mi
from
Oxnard, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Wilshire Oncology Medical Center
mi
from
Pomona, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Wilshire Oncology Medical Center
mi
from
Pomona, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Salinas Valley Memorial Hospital
mi
from
Salinas, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Salinas Valley Memorial Hospital
mi
from
Salinas, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Cancer Center of Santa Barbara
mi
from
Santa Barbara, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Cancer Center of Santa Barbara
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Sansum Medical Clinic
mi
from
Santa Barbara, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Sansum Medical Clinic
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
James L. Poth, M.D., Michael Alexander, M.D., Inc.
mi
from
Santa Cruz, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
James L. Poth, M.D., Michael Alexander, M.D., Inc.
mi
from
Santa Cruz, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Marian Medical Center
mi
from
Santa Maria, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Marian Medical Center
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Office of Marilou Terpenning
mi
from
Santa Monica, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Office of Marilou Terpenning
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated:  10/28/2015
Office of Robert C. Klein
mi
from
Santa Monica, CA
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Status: Enrolling
Updated: 10/28/2015
Office of Robert C. Klein
mi
from
Santa Monica, CA
Click here to add this to my saved trials